share_log

Morgan Stanley Downgrades Treace Medical Concepts to Equal-Weight, Lowers Price Target to $5.5

Morgan Stanley Downgrades Treace Medical Concepts to Equal-Weight, Lowers Price Target to $5.5

摩根士丹利將Treace Medical Concepts的評級下調至同等權重,將目標股價下調至5.5美元
Benzinga ·  05/08 11:47

Morgan Stanley analyst Drew Ranieri downgrades Treace Medical Concepts (NASDAQ:TMCI) from Overweight to Equal-Weight and lowers the price target from $15 to $5.5.

摩根士丹利分析師德魯·拉涅利將Treace Medical Concepts(納斯達克股票代碼:TMCI)的評級從增持下調至同等,並將目標股價從15美元下調至5.5美元。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論